Skip to content

Efficacy of Dark Chocolate in Achalasia Patients

Efficacy of Dark Chocolate in Achalasia Patients: Placebo-Controlled Study

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00790465
Enrollment
40
Registered
2008-11-13
Start date
2008-11-30
Completion date
2010-11-30
Last updated
2008-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia

Keywords

achalasia, lower esophageal sphincter, nitric oxide, dark chocolate, flavanols

Brief summary

Flavanols, present in dark chocolate, were shown to induce Nitric Oxide synthesis. Since Nitric Oxide facilitates smooth muscle relaxation, it might ease the relaxation of the LES (lower esophageal sphincter)as well. The objective of the present study is to evaluate tha efficacy of dark chocolate in improving LES relaxation in achalasia patients.

Interventions

DIETARY_SUPPLEMENTdark chocolate

21 g/d of dark chocolate for 2 weeks (7 g. before each meal). 7 grams of dark chocolate at day 1 during manometry.

DIETARY_SUPPLEMENTplacebo chocolate with crossover to dark chocolate

Placebo at day 1 during manometry, and than crossover to dark chocolate for 2 weeks treatment.

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of achalasia * Achalasia diagnosis during manometry at day 1 of the study.

Exclusion criteria

* pregnancy * pseudoachalasia * consumption of GI-motility modifiers durin 72 hours preceding the study.

Design outcomes

Primary

MeasureTime frame
Lower Esophageal Sphincter relaxation before and after dark chocolate consumption.day 1

Secondary

MeasureTime frame
achalasia symptoms before and during dark-chocolate consumption2 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026